Heterozygous pathogenic UROD variants are typically associated with porphyria cutanea tarda (PCT), while homozygous or compound heterozygous variants cause hepatoerythropoietic porphyria (HEP), a rarer and more severe phenotype. Here, UROD is linked to hepatoerythropoietic porphyria.